NaBen® — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-30 in 3mo
ESTIMATED |
READOUT
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled
Phase 2/3 · Refractory Schizophrenia |
SyneuRx International (Taiwan) Cor | NaBen® |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|